Toward Superbug-Free Societies
Connected AMR & One Health capabilities
Key Capabilities
Clinical & Healthcare Intelligence
Illustrative case context, laboratory evidence and stewardship references.
AMR Surveillance & Analytics
Illustrative trends across organisms, antimicrobials and care settings.
Biosecurity & One Health
Connected human, animal and environmental intelligence.
GIS AMR Surveillance
Saudi, GCC, Middle East and global maps with illustrative geographic signals.
Research & Analytics
Research projects, evidence resources and illustrative epidemiological analysis.
Training & Awareness
AMR learning pathways, stewardship education and community awareness.
Explore GermQ Intelligence
Alerts
Review illustrative early warnings and follow alert investigations.
Antibiogram Intelligence
Explore source-verified 2023 and 2024 hospital susceptibility reports.
Surveillance
Compare illustrative organism trends, care settings and surveillance signals.
Policy
Explore documented AMR policy priorities and coordinated action.
Policy Report
Read the GMWHO 2024 policy report and its recommendations.
Demographics
Explore illustrative age-group and risk-factor visualizations, not patient case counts.
Four connected pillars
One platform. A shared picture.
Clinical Intelligence & Precision Care
Patient context, laboratory evidence and stewardship review.
AMR Data & Predictive Intelligence
Transparent simulated analysis of connected resistance signals.
One Health & Biosecurity
Human, animal, agricultural and environmental perspectives.
Surveillance, GIS & Early Warning
Geographic signals connected to trends and alert investigation.
Inside the intelligence workspace
Open dashboardIsolates analysed
1,284,390
illustrative illustrative value
Mean resistance rate
31.7%
illustrative illustrative value
Active alerts
18
illustrative illustrative value
Reporting sites
246
illustrative illustrative value
Illustrative operational scenarios; historical laboratory evidence is identified separately. No live surveillance, integrations or AI models are connected.
Geographic values are illustrative, not regional AMR statistics. No live systems are connected. The 2023/2024 Riyadh hospital antibiograms are separate historical evidence and are not assigned to these regions. Grey boundaries have no matching scenario data.
How GermQ Works
Connect the evidence
Bring illustrative laboratory, clinical and cross-sector context into a shared view.
Understand the signal
Explore geography, trends and transparent simulated risk interpretation.
Support coordinated review
Connect alert investigation, clinical context and One Health into a report.
ONE HEALTH
Health is connected across sectors
Human surveillance, veterinary use, agricultural context and wastewater signals meet in a illustrative example. Shared geography does not establish causation.
Explore One HealthResearch & knowledge
Technology & future integrations
Explore roadmapCurrent concept
Local illustrative data, interactive charts, GIS, role switching and scripted intelligence.
Planned AI & analysis
Python, SVM, Logistic Regression, OCR and NLP — not operational models.
Planned interoperability
HL7 FHIR, EHR/EMR, LIS and institutional APIs — no live integrations.
Future security & validation
Institutional governance, access controls, clinical evaluation and external validation before deployment.
Historical SAIR foundation
Documented programme achievements since October 2016 — historical SAIR results, not measured GermQ outcomes.
Beneficiaries
6,650
70% community members, 30% healthcare providers
Engagements (2016–2022)
850,000
324,000 total views
Awareness campaigns
7
Riyadh, Dammam and Jeddah
Conferences
8 global · 4 local
UNDP, UNFPA, Youth Assembly, Georgetown
Media coverage
80+
TV, radio, press and reports
E-campaign reach
18,930
Videos reached 25,000 members
About GermQ
Designed around continuity of care, outbreak preparedness and responsible decision support. Saudi Arabia is the initial geographic focus, with global scalability as a future ambition.
Our mission & approachInstitutional collaboration
Proposed B2B/B2G SaaS pathways for healthcare institutions, researchers and public-health organisations. No active customers or GermQ partnerships are claimed.